But of course, we know that because malaria impacted on areas where there was not considered to be a return on the investment, many pharmaceutical companies just did not spend time trying to come up with a cure or a prevention, because they figured if they did, who could pay for it?
Payne discussed pharmaceutical companies' reluctance to invest in malaria solutions.
Share
More from Donald M. Payne
I was unable to cast my vote for Roll Call Nos. 105 and 106. Had I been present, I would have voted ``yea'' on rollcall Vote No. 105, H.R. 6655 and ``yea'' on rollcall Vote No. 106, S. 2051. =========================== NOTE…
I was unable to cast my vote today. Had I been present, I would have voted ``nay'' on rollcall No. 107, Ordering the Previous Question on H. Res. 1125; ``nay'' on rollcall No. 108, H. Res. 1125; and ``yea'' on rollcall No. 109, H.R. 3250…
I thank the gentleman for yielding, and I thank my colleague, Mr. Jackson of the great State of Illinois, for the opportunity to speak with you today. Let me acknowledge my colleagues who are leading this fight, the Honorable Cori Bush…
I thank the gentlewoman from Florida and the gentleman from Illinois for leading this Special Order hour, which is a great responsibility given to them by the chairman of this body. Mr. Speaker, I rise today to address the recent expulsion…
Other voices in this conversation
